# Perceptive Advisors' Biotech Investments: 101 Startups in Its Portfolio (2026) > The 101 Biotech startups Perceptive Advisors has backed, by stage: $24B raised between them. From the rounds we track; updated nightly. Source: https://millionrounds.com/portfolio-maps/perceptive-advisors-biotech-portfolio (Millionrounds; every figure on the page links to its filing or article) ## Stage not reported 39 - [BridgeBio](https://millionrounds.com/company/bridgebio) - [Apogee Therapeutics](https://millionrounds.com/company/apogee-therapeutics) - [Oruka Therapeutics](https://millionrounds.com/company/oruka-therapeutics) - [Spyre Therapeutics](https://millionrounds.com/company/spyre-therapeutics) - [IDEAYA Biosciences](https://millionrounds.com/company/ideaya-biosciences) - [Freenome](https://millionrounds.com/company/freenome) - [*CT* Cerevel Therapeutics](https://millionrounds.com/company/cerevel-therapeutics) - [Taysha Gene Therapies](https://millionrounds.com/company/taysha-gene-therapies) - [Allogene Therapeutics](https://millionrounds.com/company/allogene-therapeutics) - [4D Molecular Therapeutics](https://millionrounds.com/company/4d-molecular-therapeutics) - [Rapt Therapeutics](https://millionrounds.com/company/rapt-therapeutics) - [Rapport Therapeutics](https://millionrounds.com/company/rapport-therapeutics) - [Nurix Therapeutics](https://millionrounds.com/company/nurix-therapeutics) - [Forte Biosciences](https://millionrounds.com/company/forte-biosciences) - [MeiraGTx](https://millionrounds.com/company/meiragtx) - [VitalConnect](https://millionrounds.com/company/vitalconnect) - [Cogent Biosciences](https://millionrounds.com/company/cogent-biosciences) - [COMPASS Pathways](https://millionrounds.com/company/compass-pathways) - [Crescent Biopharma](https://millionrounds.com/company/crescent-biopharma) - [Amylyx Pharmaceuticals](https://millionrounds.com/company/amylyx-pharmaceuticals) - [Celladon](https://millionrounds.com/company/celladon) - [True North Therapeutics](https://millionrounds.com/company/true-north-therapeutics) - [TELA Bio](https://millionrounds.com/company/tela-bio) - [Acrivon Therapeutics](https://millionrounds.com/company/acrivon-therapeutics) +15 more ## Series C and later 27 - [Blueprint Medicines](https://millionrounds.com/company/blueprint-medicines) - [Relay Therapeutics](https://millionrounds.com/company/relay-therapeutics) - [Zymergen](https://millionrounds.com/company/zymergen) - [Avidity Biosciences](https://millionrounds.com/company/avidity-biosciences) - [Orchard Therapeutics](https://millionrounds.com/company/orchard-therapeutics) - [Outset Medical](https://millionrounds.com/company/outset-medical) - [Solid Biosciences](https://millionrounds.com/company/solid-biosciences) - [Beta Bionics](https://millionrounds.com/company/beta-bionics) - [Pear Therapeutics](https://millionrounds.com/company/pear-therapeutics) - [Science 37](https://millionrounds.com/company/science-37) - [Alector](https://millionrounds.com/company/alector) - [Counsyl](https://millionrounds.com/company/counsyl) - [Sionna Therapeutics](https://millionrounds.com/company/sionna-therapeutics) - [RayzeBio](https://millionrounds.com/company/rayzebio) - [CereVasc](https://millionrounds.com/company/cerevasc) - [ArcherDX](https://millionrounds.com/company/archerdx) - [Emulate](https://millionrounds.com/company/emulate) - [Endeavor BioMedicines](https://millionrounds.com/company/endeavor-biomedicines) - [ReViral](https://millionrounds.com/company/reviral) - [Escient Pharmaceuticals](https://millionrounds.com/company/escient-pharmaceuticals) - [Dynacure](https://millionrounds.com/company/dynacure) - [Genome Medical](https://millionrounds.com/company/genome-medical) - [Forge Biologics](https://millionrounds.com/company/forge-biologics) - [Clearside Biomedical](https://millionrounds.com/company/clearside-biomedical) +3 more ## Series B 20 - [Akero Therapeutics](https://millionrounds.com/company/akero-therapeutics) - [*CT* Cidara Therapeutics](https://millionrounds.com/company/cidara-therapeutics) - [SpringWorks Therapeutics](https://millionrounds.com/company/springworks-therapeutics) - [Beam Therapeutics](https://millionrounds.com/company/beam-therapeutics) - [Fulcrum Therapeutics](https://millionrounds.com/company/fulcrum-therapeutics) - [Stoke Therapeutics](https://millionrounds.com/company/stoke-therapeutics) - [Marea Therapeutics](https://millionrounds.com/company/marea-therapeutics) - [scPharmaceuticals](https://millionrounds.com/company/scpharmaceuticals) - [*CT* Capstan Therapeutics](https://millionrounds.com/company/capstan-therapeutics) - [Black Diamond Therapeutics](https://millionrounds.com/company/black-diamond-therapeutics) - [Graphite Bio](https://millionrounds.com/company/graphite-bio) - [Achilles Therapeutics](https://millionrounds.com/company/achilles-therapeutics) - [SonoThera](https://millionrounds.com/company/sonothera) - [Pheon Therapeutics](https://millionrounds.com/company/pheon-therapeutics) - [*FP* Fusion Pharamaceuticals](https://millionrounds.com/company/fusion-pharamaceuticals) - [Confo Therapeutics](https://millionrounds.com/company/confo-therapeutics) - [*I* Ideaya](https://millionrounds.com/company/ideaya) - [GenSight Biologics](https://millionrounds.com/company/gensight-biologics) - [Zentera Therapeutics](https://millionrounds.com/company/zentera-therapeutics) - [*LB* Landos Biopharma](https://millionrounds.com/company/landos-biopharma) ## Series A 15 - [Nuvation Bio](https://millionrounds.com/company/nuvation-bio) - [*CP* CinCor Pharma](https://millionrounds.com/company/cincor-pharma) - [Kronos Bio](https://millionrounds.com/company/kronos-bio) - [Merida Biosciences](https://millionrounds.com/company/merida-biosciences) - [Axonis Therapeutics](https://millionrounds.com/company/axonis-therapeutics) - [*A* AavantiBio](https://millionrounds.com/company/aavantibio) - [Fusion Pharmaceuticals](https://millionrounds.com/company/fusion-pharmaceuticals) - [Oncorus](https://millionrounds.com/company/oncorus) - [Saama](https://millionrounds.com/company/saama) - [Partner Therapeutics](https://millionrounds.com/company/partner-therapeutics) - [Synlogic](https://millionrounds.com/company/synlogic) - [Xontogeny](https://millionrounds.com/company/xontogeny) - [*QB* Quellis Biosciences](https://millionrounds.com/company/quellis-biosciences) - [*V* Vitruvias](https://millionrounds.com/company/vitruvias) - [AsclepiX Therapeutics](https://millionrounds.com/company/asclepix-therapeutics) ## Segment by segment ### Stage not reported 39 startups · $11B raised - [**BridgeBio**](https://millionrounds.com/company/bridgebio) BridgeBio focuses on the development and commercialization of precision medicines for various genetic diseases and cancers. United States $1.4B - [**Apogee Therapeutics**](https://millionrounds.com/company/apogee-therapeutics) Apogee Therapeutics is a biotechnology company that offers therapies for immunological and inflammatory disorders. United States $1.3B - [**Oruka Therapeutics**](https://millionrounds.com/company/oruka-therapeutics) Oruka Therapeutics is advancing innovative biologics to redefine patient care standards in chronic skin diseases. United States $880M - [**Spyre Therapeutics**](https://millionrounds.com/company/spyre-therapeutics) Spyre Therapeutics is a biotechnology business that is developing a strong pipeline of antibody therapies. United States $678M - [**IDEAYA Biosciences**](https://millionrounds.com/company/ideaya-biosciences) IDEAYA Biosciences is an oncology-focused biotechnology company that develops therapeutics for patients with genetically-defined cancers. United States $608M - [**Freenome**](https://millionrounds.com/company/freenome) Freenome is a biotechnology company with a comprehensive multiomics platform for cancer detection using a routine blood draw. United States $553M - [*CT* **Cerevel Therapeutics**](https://millionrounds.com/company/cerevel-therapeutics) Cerevel Therapeutics is a biopharmaceutical company that develops drugs to treat neurological and neuropsychiatric disorders. United States $450M - [**Taysha Gene Therapies**](https://millionrounds.com/company/taysha-gene-therapies) Taysha Gene Therapies develops treatments to eradicate severe and life-threatening monogenic diseases of the central nervous system. United States $400M ### Series C and later 27 startups · $7.9B raised - [**Blueprint Medicines**](https://millionrounds.com/company/blueprint-medicines) Blueprint Medicines is a global, fully integrated biopharmaceutical company that invents life-changing medicines. United States $1.4B - [**Relay Therapeutics**](https://millionrounds.com/company/relay-therapeutics) Relay therapeutics is a developer of an allosteric drug-discovery platform intended to apply computational techniques to protein motion. United States $932M - [**Zymergen**](https://millionrounds.com/company/zymergen) United States $874M - [**Avidity Biosciences**](https://millionrounds.com/company/avidity-biosciences) Synapse Energy Economics is a consulting firm providing economic and policy analysis for the electric power sector. United States $790M - [**Orchard Therapeutics**](https://millionrounds.com/company/orchard-therapeutics) Orchard Therapeutics is a biotechnology company dedicated to assisting patients through innovative gene therapies. United Kingdom $377M - [**Outset Medical**](https://millionrounds.com/company/outset-medical) Outset Medical is a medical technology company that offers reimagining dialysis for patients and providers. United States $360M - [**Solid Biosciences**](https://millionrounds.com/company/solid-biosciences) Solid Biosciences is a life science company that conducts research for the treatment of Duchenne muscular dystrophy. United States $333M - [**Beta Bionics**](https://millionrounds.com/company/beta-bionics) Beta Bionics is a biotechnology company that develops an integrated bionic pancreas system called the iLet. United States $296M ### Series B 20 startups · $4.0B raised - [**Akero Therapeutics**](https://millionrounds.com/company/akero-therapeutics) Akero Therapeutics is a biotechnology company focused on reversing the NASH epidemic by restoring the body’s metabolism to a balanced state. United States $502M - [*CT* **Cidara Therapeutics**](https://millionrounds.com/company/cidara-therapeutics) Cidara Therapeutics is a biotechnology company that specializes in the fields of healthcare and therapeutics. United States $463M - [**SpringWorks Therapeutics**](https://millionrounds.com/company/springworks-therapeutics) SpringWorks Therapeutics is a biopharmaceutical company that develops medicines for patients with severe rare diseases and cancer. United States $400M - [**Beam Therapeutics**](https://millionrounds.com/company/beam-therapeutics) Beam Therapeutics is a biotechnology company developing precision genetic medicines through the use of base editing technology. United States $322M - [**Fulcrum Therapeutics**](https://millionrounds.com/company/fulcrum-therapeutics) Fulcrum Therapeutics is a biotechnology company that focuses on identifying and treating rare genetic diseases at their root cause. United States $310M - [**Stoke Therapeutics**](https://millionrounds.com/company/stoke-therapeutics) Stoke is developing antisense oligonucleotide medicines that target RNA splicing to increase gene expression for treatment. United States $255M - [**Marea Therapeutics**](https://millionrounds.com/company/marea-therapeutics) Marea is a biotechnology firm that uses the advancements in human genetics next-generation medications for cardiometabolic illnesses. United States $190M - [**scPharmaceuticals**](https://millionrounds.com/company/scpharmaceuticals) ScPharmaceuticals is a biopharmaceutical company developing a portfolio of transformative pharmaceutical products for subcutaneous delivery. United States $187M ### Series A 15 startups · $1.8B raised - [**Nuvation Bio**](https://millionrounds.com/company/nuvation-bio) Nuvation Bio is a global biopharmaceutical company focusing on unmet needs in oncology. United States $675M - [*CP* **CinCor Pharma**](https://millionrounds.com/company/cincor-pharma) CinCor is a clinical-stage biopharmaceutical company that develops treatments for cardiovascular diseases. United States $275M - [**Kronos Bio**](https://millionrounds.com/company/kronos-bio) Kronos Bio focuses on the research and development of first-in-class therapies that modulate historically recalcitrant cancer. United States $123M - [**Merida Biosciences**](https://millionrounds.com/company/merida-biosciences) Merida Biosciences is a biotechnology company based in Cambridge, Massachusetts, focused on developing precision medicines for aut United States $121M - [**Axonis Therapeutics**](https://millionrounds.com/company/axonis-therapeutics) Axonis Therapeutics is a Boston-based biotechnology company founded in 2019, focused on developing innovative oral therapies for n United States $115M - [*A* **AavantiBio**](https://millionrounds.com/company/aavantibio) AavantiBio is a biopharmaceutical company that provides gene transfer and gene editing therapies to treat genetic diseases. - $107M - [**Fusion Pharmaceuticals**](https://millionrounds.com/company/fusion-pharmaceuticals) Fusion Pharmaceuticals is a clinical-stage oncology company focused on developing radiopharmaceuticals. Canada $85M - [**Oncorus**](https://millionrounds.com/company/oncorus) Oncorus is an immuno-oncology company developing oncolytic viruses to fight cancer. United States $77M **How this map is made.** Every startup here works in Biotech and has raised money in a round we track that names Perceptive Advisors as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026. ## More portfolio maps [All portfolios](https://millionrounds.com/portfolio-maps) [Sector portfolio **Perceptive Advisors' Pharma portfolio** 18 startups · $2.5B](https://millionrounds.com/portfolio-maps/perceptive-advisors-pharma-portfolio)[Portfolio map **Perceptive Advisors portfolio map** 133 startups · $28B](https://millionrounds.com/portfolio-maps/perceptive-advisors-portfolio-map)[Co-investors **Who invests with Perceptive Advisors** 116 co-investors](https://millionrounds.com/portfolio-maps/perceptive-advisors-co-investors)[Sector portfolio **BlackRock's AI portfolio** 41 startups · $529B](https://millionrounds.com/portfolio-maps/blackrock-ai-portfolio)[Sector portfolio **BlackRock's Fintech portfolio** 25 startups · $17B](https://millionrounds.com/portfolio-maps/blackrock-fintech-portfolio)[Sector portfolio **BlackRock's Biotech portfolio** 19 startups · $4.2B](https://millionrounds.com/portfolio-maps/blackrock-biotech-portfolio) ## Raising from investors like Perceptive Advisors? Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports. [Find investors](https://millionrounds.com/login?join=1&next=/app/investors)[Market maps](https://millionrounds.com/market-maps)